The prevalence of a heparin-like effect shown on the thromboelastograph in patients undergoing liver transplantation
Open Access
- 28 May 2008
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Liver Transplantation
- Vol. 14 (6), 855-860
- https://doi.org/10.1002/lt.21437
Abstract
It has been known for several decades that thromboelastographic analysis of the blood of patients undergoing liver transplantation may show a heparin‐like effect (HLE) at the time of reperfusion. However, the prevalence of HLE and the origin of these heparin‐like substances remain largely unstudied. The primary aim of this retrospective observational analysis was to determine the prevalence of the HLE in 211 consecutive patients having liver transplantation in our institution at various stages throughout the transplant. One of the secondary aims was to analyze the prevalence of HLE with respect to the various etiologies of liver disease. Paired Thromboelastograph traces (native and heparinase) were examined at 5 stages of the transplant: the baseline stage, dissection stage, anhepatic stage, reperfusion stage, and end of the case. HLE was defined as a reduction in the reaction and coagulation times of greater than 50% by the addition of heparinase to the sample. Thirty‐one percent of patients had evidence of an HLE at baseline, and this increased to 75% after reperfusion of the donor graft. This HLE resolved spontaneously in 47% by the end of the case. Patients with fulminant liver failure were more likely to demonstrate HLE at baseline than those with chronic liver disease (45.8% compared to 29%). There was no difference in the prevalence of HLE after reperfusion. In conclusion, prior to transplantation, there is a significant difference in the prevalence of HLE with respect to etiology. However, this difference disappears after reperfusion as the majority of patients then develop HLE. Although it is clear that there are both endogenous and exogenous sources of heparin contributing to the HLE, the clinical significance of these findings remains unclear. Liver Transpl 14:855–860, 2008. © 2008 AASLD.Keywords
This publication has 21 references indexed in Scilit:
- The effects of glycosaminoglycans on coagulation: a thromboelastographic studyBlood Coagulation & Fibrinolysis, 2007
- Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thrombelastographyJournal of Thrombosis and Haemostasis, 2005
- Endogenous heparin‐like activity detected by anti‐Xa assay in infected cirrhotic and non‐cirrhotic patientsScandinavian Journal of Gastroenterology, 2004
- Endogenous Heparin-Like Substances Significantly Impair Coagulation in Patients Undergoing Orthotopic Liver TransplantationAnesthesia & Analgesia, 1998
- Coagulation and liver transplantation: Current conceptsLiver Transplantation and Surgery, 1997
- Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastographyJournal of Hepatology, 1997
- Coagulation and fibrinolysis in primary biliary cirrhosis compared with other liver disease and during orthotopic liver transplantationHepatology, 1997
- THE APPEARANCE OF DONOR HEPARIN IN THE RECIPIENT AFTER REPERFUSION OF A LIVER GRAFTTransplantation, 1993
- Plasma concentrations of endogenous heparinoids in portal hypertension.Gut, 1992
- Pharmacotherapeutic Aspects of Unfractionated and Low Molecular Weight HeparinsDrugs, 1990